Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Riding on Rohit Sharma's 119, India chased down England's 304 with 33 balls to spare and four wickets in hand. India thus win ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

A biomaterial that can mimic certain behaviors within biological tissues could advance regenerative medicine, disease modeling, soft robotics and more, according to researchers.

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...

Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the closing of a public offering of an ...

Credit: Vitalii Petrushenko via Getty Images. The UK biotech sector raised £3.5bn in 2024, marking a 94% increase from the previous year, according to the BioIndustry Association’s (BIA) annual ...

That, combined with tight funding in biotech, has led to a flurry of licensing ... It’s in multi-country Phase 3 trials in CML, as well as for two other forms of cancer. Though similar drugs, such as ...

But it does – and the Tesla Model 3 is the best known. It is, famously, a fully electric car – Tesla doesn’t do petrols, diesels or even hybrids – and it’s the US brand’s smallest and ...